Journal article

IMMUNE PHAGOCYTOSIS INHIBITION BY COMMERCIAL IMMUNOGLOBULINS


Authors listNEPPERT, J; CLEMENS, M; MUELLERECKHARDT, C

Publication year1986

Pages67-72

JournalBlut

Volume number52

Issue number2

ISSN0006-5242

Open access statusBronze

DOI Linkhttps://doi.org/10.1007/BF00321069

PublisherSpringer


Abstract
Sixteen commercially available immunoglobulins (Ig) and 5 anti-Rho(D) hyperimmune globulins were investigated for immune phagocytosis inhibition (IPI) factors as well as for T, B lymphocytotoxic and monocytotoxic antibodies. All Ig contained IPI factors with lowest inhibitory IgG concentrations ranging from 0.08 to 50 mg/ml. Pepsin-digested Ig was noninhibitory. IPI factors in anti-D preparations were uniformly high (inhibitory IgG concentrations 0.6-2.5 mg/ml). Cytotoxic antibodies against T, B lymphocytes and monocytes were found in 2,2 and 7 products, respectively. Since we have recently shown that IPI is caused by antibodies against major histocompatibility complex antigens, most likely HLA, the hypothesis is put forward that IPI factors in Ig are HLA-related, cytotoxic as well as noncytotoxic antibodies which act via Fc receptor blockade of human monocytes.



Citation Styles

Harvard Citation styleNEPPERT, J., CLEMENS, M. and MUELLERECKHARDT, C. (1986) IMMUNE PHAGOCYTOSIS INHIBITION BY COMMERCIAL IMMUNOGLOBULINS, Blut, 52(2), pp. 67-72. https://doi.org/10.1007/BF00321069

APA Citation styleNEPPERT, J., CLEMENS, M., & MUELLERECKHARDT, C. (1986). IMMUNE PHAGOCYTOSIS INHIBITION BY COMMERCIAL IMMUNOGLOBULINS. Blut. 52(2), 67-72. https://doi.org/10.1007/BF00321069


Last updated on 2025-10-06 at 12:14